Literature DB >> 23322471

Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome.

Ricardo A G Russo1, María M Katsicas.   

Abstract

OBJECTIVE: Systemic juvenile idiopathic arthritis (SJIA) frequently leads to disability and damage. Predictive factors for a poor outcome include persistent systemic features and younger age at onset. We describe and analyze disease features in patients with early-onset (EO) SJIA (disease onset before age 18 mo) and compare them to patients with later-onset (LO) disease.
METHODS: Clinical features at onset, activity measures (occurrence of macrophage activation syndrome, remission), and outcome measures for disability [Childhood Health Assessment Questionnaire (CHAQ) ≥ 0.5] and damage [radiographic joint destruction, Juvenile Arthritis Damage Index (JADI) score, growth retardation] observed during followup were analyzed retrospectively in patients with SJIA followed for ≥ 3 years since disease onset.
RESULTS: In total 132 patients were included. SJIA started at age ≤ 18 months in 19 (14%) patients and at a later age in 113 (86%) children. At onset, serositis (p < 0.01) and hepatomegaly (p < 0.05) were more frequent in EO patients, who also exhibited lower hemoglobin levels (p < 0.03) and higher platelet counts (p < 0.03) than patients with LO. Macrophage activation syndrome occurred in 20 patients (11 EO and 9 LO; p < 0.0001). Remission was achieved by 49 patients (37%; 4 EO and 45 LO). At last visit, destructive hip disease (p < 0.04), growth retardation (p < 0.01), radiographic damage (p < 0.02), and disability (p < 0.04) were more frequent in patients with EO disease, who had higher JADI scores (p < 0.003).
CONCLUSION: Patients with EO exhibited a more aggressive and destructive disease course than patients with LO SJIA.

Entities:  

Mesh:

Year:  2013        PMID: 23322471     DOI: 10.3899/jrheum.120386

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

Review 1.  Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.

Authors:  Sathish Kumar
Journal:  Indian J Pediatr       Date:  2016-02-26       Impact factor: 1.967

2.  Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.

Authors:  Hatice Ezgi Baris; Edwin Anderson; Betul Sozeri; Fatma Dedeoglu
Journal:  Clin Rheumatol       Date:  2018-09-20       Impact factor: 2.980

Review 3.  Imaging of the hip in juvenile idiopathic arthritis.

Authors:  Susan Cheng Shelmerdine; Pier Luigi Di Paolo; Laura Tanturri de Horatio; Clara Malattia; Silvia Magni-Manzoni; Karen Rosendahl
Journal:  Pediatr Radiol       Date:  2018-05-08

4.  Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis.

Authors:  Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2019-09-22       Impact factor: 10.995

5.  Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic Arthritis.

Authors:  Siobhan M Case; Peter A Nigrovic
Journal:  Paediatr Drugs       Date:  2022-04-01       Impact factor: 3.022

Review 6.  Clinical Outcome and Long-term Remission in JIA.

Authors:  Mia Glerup; T Herlin; M Twilt
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

Review 7.  Review: Genetics and the Classification of Arthritis in Adults and Children.

Authors:  Peter A Nigrovic; Soumya Raychaudhuri; Susan D Thompson
Journal:  Arthritis Rheumatol       Date:  2017-12-01       Impact factor: 10.995

Review 8.  Biological classification of childhood arthritis: roadmap to a molecular nomenclature.

Authors:  Peter A Nigrovic; Robert A Colbert; V Michael Holers; Seza Ozen; Nicolino Ruperto; Susan D Thompson; Lucy R Wedderburn; Rae S M Yeung; Alberto Martini
Journal:  Nat Rev Rheumatol       Date:  2021-03-17       Impact factor: 20.543

9.  Emergent high fatality lung disease in systemic juvenile arthritis.

Authors:  Gail H Deutsch; R Paul Guillerman; Johannes Birgmeier; Karthik Jagadeesh; Scott Canna; Grant Schulert; Vivian E Saper; Guangbo Chen; Robin Deterding; Jianpeng Xu; Ann N Leung; Layla Bouzoubaa; Khalid Abulaban; Kevin Baszis; Edward M Behrens; James Birmingham; Alicia Casey; Michal Cidon; Randy Q Cron; Aliva De; Fabrizio De Benedetti; Ian Ferguson; Martha P Fishman; Steven I Goodman; T Brent Graham; Alexei A Grom; Kathleen Haines; Melissa Hazen; Lauren A Henderson; Assunta Ho; Maria Ibarra; Christi J Inman; Rita Jerath; Khulood Khawaja; Daniel J Kingsbury; Marisa Klein-Gitelman; Khanh Lai; Sivia Lapidus; Clara Lin; Jenny Lin; Deborah R Liptzin; Diana Milojevic; Joy Mombourquette; Karen Onel; Seza Ozen; Maria Perez; Kathryn Phillippi; Sampath Prahalad; Suhas Radhakrishna; Adam Reinhardt; Mona Riskalla; Natalie Rosenwasser; Johannes Roth; Rayfel Schneider; Dieneke Schonenberg-Meinema; Susan Shenoi; Judith A Smith; Hafize Emine Sönmez; Matthew L Stoll; Christopher Towe; Sara O Vargas; Richard K Vehe; Lisa R Young; Jacqueline Yang; Tushar Desai; Raymond Balise; Ying Lu; Lu Tian; Gill Bejerano; Mark M Davis; Purvesh Khatri; Elizabeth D Mellins
Journal:  Ann Rheum Dis       Date:  2019-09-27       Impact factor: 19.103

10.  Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.

Authors:  Ji Won Yang; Eunyoung Lee; Ji-Yeon Seo; Ju-Yang Jung; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-25       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.